NGRDX
Price
$32.98
Change
+$0.31 (+0.95%)
Updated
Sep 4 closing price
Net Assets
2.64B
RGEBX
Price
$82.44
Change
+$0.19 (+0.23%)
Updated
Sep 5 closing price
Net Assets
331.65B
Interact to see
Advertisement

NGRDX vs RGEBX

Header iconNGRDX vs RGEBX Comparison
Open Charts NGRDX vs RGEBXBanner chart's image
Neuberger Berman Large Cap Growth R6
Price$32.98
Change+$0.31 (+0.95%)
VolumeN/A
Net Assets2.64B
American Funds Growth Fund of Amer R2E
Price$82.44
Change+$0.19 (+0.23%)
VolumeN/A
Net Assets331.65B
NGRDX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
NGRDX vs. RGEBX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGRDX is a StrongBuy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 332B vs. NGRDX (2.64B). NGRDX pays higher dividends than RGEBX: NGRDX (0.24) vs RGEBX (0.00). NGRDX was incepted earlier than RGEBX: NGRDX (6 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than NGRDX (0.60). NGRDX is a more actively managed with annual turnover of: 30.00 vs. RGEBX (25.00). NGRDX has a lower initial minimum investment than RGEBX: NGRDX (0) vs RGEBX (250). RGEBX (17.59) and NGRDX (16.75) have marching annual gain over last year. NGRDX return over 5 years is better than : 46.88 vs. RGEBX (38.71).
NGRDXRGEBXNGRDX / RGEBX
Total Expense Ratio0.561.0951%
Annual Report Gross Expense Ratio0.601.0955%
Fund Existence6 years11 years-
Gain YTD12.59815.39882%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.64B332B1%
Annual Yield % from dividends0.240.00-
Returns for 1 year16.7517.5995%
Returns for 3 years53.4657.6193%
Returns for 5 years46.8838.71121%
Returns for 10 yearsN/A91.44-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARTV3.610.50
+16.08%
Artiva Biotherapeutics Inc
ARCT17.851.09
+6.50%
Arcturus Therapeutics Holdings
MANH215.315.45
+2.60%
Manhattan Associates
TRMD23.020.25
+1.10%
TORM plc
INDP3.30-1.31
-28.35%
Indaptus Therapeutics Inc